Castration Levels of Testosterone: Clinical Trials

6 trials for Castration Levels of Testosterone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 11Completed 1

Follow Castration Levels of Testosterone: new trials by email Literature Review of Castration Levels of Testosterone trials Research Report on Castration Levels of Testosterone

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
Apalutamide, Stereotactic Body Radiation Therapy - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma
Phase 2CompletedUniversity of California, San Francisco262019-12-172026-01-21
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
HER2Bi-Armed Activated T Cells, Laboratory Biomarker Analysis, Pembrolizumab - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma
Phase 2CompletedBarbara Ann Karmanos Cancer Institute152018-06-072023-05-03
ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer
ESK981 - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma
Phase 2CompletedBarbara Ann Karmanos Cancer Institute132018-03-082023-07-14
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway
Carboplatin, Docetaxel, Laboratory Biomarker Analysis - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma
Phase 2CompletedUniversity of Washington142016-01-262022-11-17
CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer
Glycosylated Recombinant Human Interleukin-7, Laboratory Biomarker Analysis - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma
Phase 2CompletedFred Hutchinson Cancer Center542013-09-102019-07-09
Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer
Cabazitaxel, Carboplatin, Laboratory Biomarker Analysis - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center1702012-07-112021-07-30

Narrower conditions

Prostatic Neoplasms (4)  ·  Lymphadenopathy (1)

Broader conditions

Genital Diseases (4)  ·  Genital Diseases, Male (4)  ·  Genital Neoplasms, Male (4)  ·  Male Urogenital Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Prostatic Diseases (4)  ·  Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Hemic and Lymphatic Diseases (1)  ·  Lymphatic Diseases (1)

Interventions

Carboplatin (2)  ·  Docetaxel (1)  ·  Radiosurgery (1)  ·  XRP6258 (1)  ·  apalutamide (1)  ·  cabazitaxel (1)  ·  pembrolizumab (1)

Sponsors

Barbara Ann Karmanos Cancer Institute (2)  ·  Fred Hutchinson Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  University of California, San Francisco (1)  ·  University of Washington (1)

Countries

United States (6)

Top investigators

Abhinav Deol, M.D. (1)  ·  Elisabeth I. Heath (1)  ·  Heather H. Cheng (1)  ·  Lawrence Fong (1)  ·  Martin A. Cheever (1)  ·  Paul Corn (1)  ·  Rahul Aggarwal, MD (1)

Results publications

PMID 31515154, PMID 37981040, PMID 39227508

NIH funding

P30CA015704 (2), P30CA022453 (2), P50CA097186 (2), P30CA016672 (1), U01CA154967 (1)